The Bioinformatic and Expression Analysis of PSMD4 Gene
26S proteasome non-ATPase subunit 4 (PSMD4) that has a molecular weight of 41 kDa is included on
chromosome 1 (1q21.3). PSMD4 protein is a subunit of the 19S regulatory region in the 26S proteasome.
The proteasome breaks down proteins that are not needed or non-functional in the cell. We have limited data
about the regulation of this gene in the literature. In our research, changes in the mRNA and protein levels
of the PSMD4 gene were investigated in different cancer cell lines (prostate, breast, colon, cervix, hepatoma,
osteosarcoma and pancreas) and a normal cell (human vein endothelial cell). The highest expression of PSMD4
gene was seen in HUVEC and PC-3 cells. Bioinformatic analysis was also performed on PSMD4 protein for
different species namely human, mouse and rat. Our Bioinformatic analyses showed that first 250 nucleotides
are much conserved in all three species.
___
- H. Lodish, A. Berk, P. Matsudaira, C.A. Kaiser, M.
Krieger, M.P. Scott, S.L. Zipursky, J. Darnell, Molecular
cell biology, (2004) 66–72.
- J. Adams, The proteasome: structure, function and
role in the cell, Cancer Treat. Rev., 1 (2003) 3-9.
- J.D. Etlinger, A.L. Goldberg, A soluble ATP-dependent
proteolytic system responsible for the degradation of
abnormal proteins in reticulocytes, PNAS, 74 (1977)
54–58.
- N. Benaroudj, P. Zwickl, E. Seemuller, W. Baumeister,
A.L. Goldberg, ATP hydrolysis by the proteasome
regulatory complex PAN serves multiple functions in
protein degradation, Molecul. Cell, 11 (2003) 69–78.
- J.E. Nelson, A. Loukissa, C. Altschuller-Felberg, J.J.
Monaco, J.T. Fallon, C. Cardozo, Up-regulation of the
proteasome subunit LMP7 in tissues of endotoxemic
rats. J. Laborat. Clin. Med., 135 (2000) 324–331.
- S. Türkoğlu, F. Köçkar, SP1 and USF differentially
regulate ADAMTS1 gene expression under normoxic
and hypoxic conditions in hepatoma cells, Gene, 575
1 (2016) 48-57.
- M. Alper and F. Köçkar, Induction of Human
ADAMTS-2 Gene Expression by IL-1α is Mediated by a
Multiple Crosstalk of MEK/JNK and PI3K Pathways in
Osteoblast like Cells, Gene, 573 (2015) 321-327.
- E.Tokay and F. Köçkar, ‘In Silico and Expression
analysis of URG-4/URGCP Gene in Different Cancer
Cells, J.Appl. Biol. Sci., 2 (2015) 13-18.
- J. Wang, M.A. Maldonado, The ubiquitin-proteasome
system and its role in inflammatory and autoimmune
diseases, Cell. Mol. Immunol., 34 (2006) 255–261.
- Y. Uyanıkgil, C. Sümer Turanlıgil, Ubikitin-proteozom
yolağının karsinojenezdeki rolü. ARŞİV, 19 (2010) 36.
- G.P. Tuszynski, V.L. Rothman, M. Papale, B.K. Hamilton,
J. Eyal, Identification and characterization of a tumor
cell receptor for CSVTCG. a thrombospondin adhesive
domain, J. Cell. Biol., 120 (1993) 513–521.
- C. Wang, H. Fan, J. Zhou, M. Lu, J. Sun, Y. Song, H. Le,
L. Jiang, B. Wang, Jiao, S5a binds to death receptor-6
to induce THP-1 monocytes to differentiate through
the activation of the NF-kB pathway, J. Cell Sci., 127
(2014) 3257–3268.
- A. Sparks, S. Dayal, J. Das, P. Robertson, S. Menendez,
MK. Saville, The degradation of p53 and its major
E3 ligase Mdm2 is differentially dependent on the
proteasomal ubiquitin receptor S5a. Oncogene,
(2013) 1–12.
- R.K. Singh, S. Zerath, O. Kleifeld, M. Scheffner, M.H.
Glickman, D. Fushman, Recognition and Cleavage
of Related to Ubiquitin 1 (Rub1) and Rub1-Ubiquitin
Chains by Components of the Ubiquitin-Proteasome
System, Mol. Cell. Proteomics, 11 (2012) 1595–1611.
- M. Elangovan, C. Oh, L. Sukumaran, C. Wójcik, Y.J. Yoo,
Functional differences between two major ubiquitin
receptors in the proteasome; S5a and hRpn13,
Biochem. Biophy. Res. Comm., 396 (2010) 425–428.
- A. Arlt, I. Bauer, C. Schafmayer, J. Tepel, S.S.
Müerköster, M. Brosch, C. Röder, H. Kalthoff,
J. Hampe, M.P. Moyer, U.R. Fölsch, H. Schafer,
Increased proteasome subunit protein expression
and proteasome activity in colon cancer relate to
an enhanced activation of nuclear factor E2-related
factor 2 (Nrf2), Oncogene, 28 (2009) 3983–3996.
- S.M. Pulukuri, C.S. Gondi, S.S. Lakka, A. Jutla, N.
Estes, M. Gujrati, J.S. Rao, RNA interference -directed
knockdown of urokinase plasminogen activator
and urokinase plasminogen activator receptor
inhibits prostate cancer cell invasion, survival, and
tumorigenicity in vivo, J. Biol. Chem., 280 (2005)
36529-36540.